Fukuda Denshi Co., Ltd. 6960
TSE · Japan · Health Technology
¥11,630.00-180.00 (-1.52%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
BOSTON, August 31, 2026--Kaname Capital, L.P. ("Kaname Capital" or "we") today published an anonymous letter that identifies problems with the Third-Party Committee investigation at Fukuda Denshi Co., Ltd. (TSE: 6960; "Fukuda Denshi"), and called on the Committee to conduct a thorough investigation.
BOSTON, July 05, 2026--Kaname Capital ("Kaname" or "we") today issued a public letter addressed to the Board of Directors, the Board of Corporate Auditors, and the Third-Party Committee of Fukuda Denshi Co., Ltd. (securities code: 6960; "Fukuda Denshi").
BOSTON, June 18, 2026--Kaname Capital ("we") today issued an open letter, "Letter of Inquiry to Your Company Following the Resignation of Chairman Fukuda," addressed to the Board of Directors and the Board of Auditors of Fukuda Denshi Co., Ltd. (Securities Code: 6960; "Fukuda Denshi").
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.